[1] THYGESEN K, ALPERT J S, JAFFE A S, et al. Third universal definition of myocardial infarction[J]. Glob Heart,2012,7(4):275-295. doi:  10.1016/j.gheart.2012.08.001
[2] EMELIA J. BENJAMIN, MICHAEL J. BLAHA, STEPHANIE E. CHIUVE. Heart disease and stroke statistics—2017 Update: A Report From the American Heart Association[J]. Circulation,2017,135(10):e146-e603.
[3] HEUSCH G, GERSH B J. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge[J]. Eur Heart J,2016:ehw224. doi:  10.1093/eurheartj/ehw224
[4] KUMAR M, KASALA E R, BODDULURU L N, et al. Animal models of myocardial infarction: Mainstay in clinical translation[J]. Regul Toxicol Pharmacol,2016,76:221-230. doi:  10.1016/j.yrtph.2016.03.005
[5] TANG Y P, LIU Y, FAN Y J, et al. To develop a novel animal model of myocardial infarction: a research imperative[J]. Anim Models Exp Med,2018,1(1):36-39. doi:  10.1002/ame2.12010
[6] GAO E H, LEI Y H, SHANG X Y, et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse[J]. Circ Res,2010,107(12):1445-1453. doi:  10.1161/CIRCRESAHA.110.223925
[7] GUO Y R, WU W J, QIU Y M, et al. Demonstration of an early and a late phase of ischemic preconditioning in mice[J]. Am J Physiol-Heart Circ Physiol,1998,275(4):H1375-H1387. doi:  10.1152/ajpheart.1998.275.4.H1375
[8] GAO F, KATAOKA M, LIU N, et al. Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction[J]. Nat Commun,2019,10:1802. doi:  10.1038/s41467-019-09530-1
[9] ROJAS S V, KENSAH G, ROTAERMEL A, et al. Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction[J]. PLoS One,2017,12(5):e0173222. doi:  10.1371/journal.pone.0173222
[10] CAHILL T J, CHOUDHURY R P, RILEY P R. Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics[J]. Nat Rev Drug Discov,2017,16(10):699-717. doi:  10.1038/nrd.2017.106
[11] TAO B, GAO H K, ZHENG M W, et al. Preclinical modeling and multimodality imaging of chronic myocardial infarction in minipigs induced by novel interventional embolization technique[J]. EJNMMI Res,2016,6(1):59. doi:  10.1186/s13550-016-0214-7
[12] KOLK M V V, MEYBERG D, DEUSE T, et al. LAD-ligation: a murine model of myocardial infarction[J]. J Vis Exp,2009,14(32):1438.
[13] MICHAEL L H, ENTMAN M L, HARTLEY C J, et al. Myocardial ischemia and reperfusion: a murine model[J]. Am J Physiol-Heart Circ Physiol,1995,269(6):H2147-H2154. doi:  10.1152/ajpheart.1995.269.6.H2147
[14] KATHERINE C. WU, JOãO A.C. LIMA. Noninvasive imaging of myocardial viability: current techniques and future developments[J]. Circ Res,2003,93(12):1146-58. doi:  10.1161/01.RES.0000103863.40055.E8
[15] GRAY G A, WHITE C I, THOMSON A, et al. Imaging the healing murine myocardial infarctin vivo: ultrasound, magnetic resonance imaging and fluorescence molecular tomography[J]. Exp Physiol,2013,98(3):606-613. doi:  10.1113/expphysiol.2012.064741
[16] CUMMINS B, AUCKLAND M L, CUMMINS P. Cardiac-specific troponin-l radioimmunoassay in the diagnosis of acute myocardial infarction[J]. Am Heart J,1987,113(6):1333-1344. doi:  10.1016/0002-8703(87)90645-4